Pharma news

Pharma news

Avoralstat Disappoints in Patients With Hereditary Angioedema

NEW YORK (Reuters Health) - A just-published trial suggests the oral plasma-kallikrein inhibitor avoralstat may cut the frequency of attacks ...

View Details
Mosquito Repellents: Everything You Need to Tell Your Patients

Thwack. They’re baaaack. Yep, it’s mosquito season again. It’s not just about itchy bumps, either -- mosquito bites can make ...

View Details
After Skin Cancer, Sun Protection Is Still Spotty

(Reuters Health) – Even though people may be more careful in the sun after skin cancer, having had a malignancy ...Read More

View Details